-
EP3281937
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3281937
| EP3281937 - SULFONAMIDES AS GPR40- AND GPR120-AGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.01.2019 Database last updated on 20.05.2024 | |
| Former | The application has been published Status updated on 12.01.2018 | Most recent event Tooltip | 11.01.2019 | Application deemed to be withdrawn | published on 13.02.2019 [2019/07] | Applicant(s) | For all designated states Dompé farmaceutici S.p.A. Via S. Martino Della Battaglia 12 20122 Milan / IT | [2018/07] | Inventor(s) | 01 /
DE PIZZOL, Maria c/o Dompé Farmaceutici S.p.A. Via Santa Lucia, 6 I-20122 Milano / IT | 02 /
SIRICO, Anna c/o Dompé Farmaceutici S.p.A. Via Pietro Castellino, 111 I-80131 Napoli / IT | 03 /
ZIPPOLI, Mara c/o Dompé Farcaceutici S.p.A. Via Pietro Castellino, 111 I-80131 Napoli / IT | 04 /
BIANCHINI, Gianluca c/o Dompé farmaceutici S.p.A. Via Campo Di Pile s.n.c. I-67100 L'Aquila / IT | 05 /
BECCARI, Andrea c/o Dompé Farcaceutici S.p.A. Via Campo di Pile s.n.c. I-67100 L'Aquila / IT | 06 /
ARAMINI, Andrea c/o Dompé farmaceutici S.p.A. Via Campo Di Pile s.n.c. I-67100 L'Aquila / IT | 07 /
LIBERATI, Chiara Rossana Maria viale Caprilli, 23 I-20148 Milano / IT | [2018/07] | Representative(s) | Viganò, Elena, et al Dragotti & Associati S.r.l. Via Nino Bixio, 7 20129 Milano / IT | [2018/07] | Application number, filing date | 16183294.4 | 09.08.2016 | [2018/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3281937 | Date: | 14.02.2018 | Language: | EN | [2018/07] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.02.2017 | Classification | IPC: | C07C311/16, C07C311/21, C07C311/51, C07D231/42, C07D235/30, C07D249/04, C07D249/08, C07D249/14, C07D257/06, C07D261/16, C07D263/50, C07D275/03, C07D277/52, C07D285/04, C07D285/135 | [2018/07] | CPC: |
C07D285/135 (EP,EA,IL,KR,US);
C07D231/42 (EP,EA,IL,KR,US);
C07C311/21 (EP,EA,IL,KR,US);
A61K31/196 (EA,KR);
A61K31/18 (IL);
A61K31/415 (EA,KR);
A61K31/4192 (EA,KR);
A61K31/4196 (EA,KR);
A61K31/426 (EA,KR);
A61K31/433 (EA,KR);
A61P19/08 (EP);
A61P19/10 (IL);
A61P3/00 (EP);
A61P3/04 (EP,EA,IL,US);
A61P3/06 (EP,EA,IL,US);
A61P3/10 (EP,EA,IL,KR,US);
C07C311/16 (EP,EA,US);
C07C311/20 (EA,US);
C07C311/29 (EA,IL,KR);
C07C311/51 (EP,EA,US);
C07D235/30 (EP,EA,IL,KR,US);
C07D249/04 (EP,EA,KR,US);
C07D249/08 (EP,EA,IL,KR,US);
C07D249/14 (EP,EA,KR,US);
C07D257/06 (EP,EA,IL,KR,US);
C07D261/04 (IL);
C07D261/16 (EP,EA,IL,KR,US);
C07D263/28 (EP,EA,US);
C07D263/30 (EA,KR,US);
C07D263/50 (EP,EA,IL,KR,US);
C07D275/03 (EP,EA,IL,US);
C07D277/52 (EP,EA,IL,KR,US);
C07D285/04 (EP,EA,KR,US);
C07D285/08 (EP,EA,IL,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/07] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | SULFONAMIDE ALS GPR40- UND GPR120-AGONISTEN | [2018/07] | English: | SULFONAMIDES AS GPR40- AND GPR120-AGONISTS | [2018/07] | French: | SULFONAMIDES EN TANT QU'AGONISTES DE GPR40 ET GPR120 | [2018/07] | Examination procedure | 15.08.2018 | Application deemed to be withdrawn, date of legal effect [2019/07] | 25.09.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2019/07] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.08.2018 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2011042465 (DOMPE SPA [IT], et al) [A] 1-17* the whole document *; | [A] - ADRIAN ET AL., "Generation of Broad Specificity Antibodies for Sulfonamide Antibiotics and Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for the Analysis of Milk Samples", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, (20090107), vol. 57, no. 2, pages 385 - 394, XP002766846 [A] 1 * page 386; compound SA3 * DOI: http://dx.doi.org/10.1021/jf8027655 | [A] - FINN PAUL W ET AL, "Novel sulfonamide derivatives as inhibitors of histone deacetylase", HELVETICA CHIMICA ACTA , 88(7), 1630-1657 CODEN: HCACAV; ISSN: 0018-019X,, (20050101), vol. 88, no. 7, pages 1630 - 1657, XP002480701 [A] 1 * page 1635; compound 26 * | by applicant | US2011184031 | WO2014073904 | WO2014209034 | US2015274672 | WO2016057731 | - HUDSON B.D. ET AL., ADV PHARMACOL, (2011), vol. 62, pages 175 - 218 | - BRISCOE C.P. ET AL., J BIOL CHEM, (2003), vol. 278, no. 13, pages 11303 - 11 | - EDFALK, S. ET AL., DIABETES, (2008), vol. 57, no. 9, pages 2280 - 7 | - LIOU A.P. ET AL., GASTROENTEROLOGY, (2011), vol. 140, no. 3, pages 903 - 12 | - HIRASAWA A. ET AL., NAT MED, (2005), vol. 11, no. 1, pages 90 - 4 | - TANEERA J. ET AL., CELL METAB, (2012), vol. 16, no. 1, pages 122 - 34 | - TANAKA T. ET AL., NAUNYN SCHMIEDEBERGS ARCH PHARMACOL, (2008), vol. 377, no. 4-6, pages 523 - 7 | - DRUCKER D.J., CELL METAB, (2006), vol. 3, no. 3, pages 153 - 65 | - MANNUCCI E. ET AL., DIABET MED, (2000), vol. 17, no. 10, pages 713 - 9 | - GOTOH C. ET AL., BIOCHEM BIOPHYS RES COMMUN, (2007), vol. 354, no. 2, pages 591 - 7 | - ICHIMURA A. ET AL., NATURE, (2012), vol. 483, no. 7389, pages 350 - 4 | - CORNISH J. ET AL., ENDOCRINOLOGY, (2008), vol. 149, no. 11, pages 5688 - 95 | - OH D.Y. ET AL., CELL, (2010), vol. 142, pages 687 - 98 | - OH D.Y. ET AL., NAT MED, (2014), vol. 20, pages 942 - 7 | - P. STAHL; C. WERMUTH, Handbook of pharmaceutical salts, WILEY-VCH, (2008), pages 127 - 133 |